Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin.

Belletti D, Pederzoli F, Forni F, Vandelli MA, Tosi G, Ruozi B.

Expert Opin Drug Deliv. 2017 Jul;14(7):825-840. doi: 10.1080/17425247.2017.1243528. Epub 2016 Oct 21. Review.

PMID:
27690258
2.

Apoferritin Nanocage for Brain Targeted Doxorubicin Delivery.

Chen Z, Zhai M, Xie X, Zhang Y, Ma S, Li Z, Yu F, Zhao B, Zhang M, Yang Y, Mei X.

Mol Pharm. 2017 Sep 5;14(9):3087-3097. doi: 10.1021/acs.molpharmaceut.7b00341. Epub 2017 Aug 2.

PMID:
28728419
3.

Glioma targeting peptide modified apoferritin nanocage.

Zhai M, Wang Y, Zhang L, Liang M, Fu S, Cui L, Yang M, Gong W, Li Z, Yu L, Xie X, Yang C, Yang Y, Gao C.

Drug Deliv. 2018 Nov;25(1):1013-1024. doi: 10.1080/10717544.2018.1464082.

4.

Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system.

Ruozi B, Veratti P, Vandelli MA, Tombesi A, Tonelli M, Forni F, Pederzoli F, Belletti D, Tosi G.

Int J Pharm. 2017 Feb 25;518(1-2):281-288. doi: 10.1016/j.ijpharm.2016.12.038. Epub 2016 Dec 23.

PMID:
28017769
5.

Ferritin nanocage with intrinsically disordered proteins and affibody: A platform for tumor targeting with extended pharmacokinetics.

Lee NK, Lee EJ, Kim S, Nam GH, Kih M, Hong Y, Jeong C, Yang Y, Byun Y, Kim IS.

J Control Release. 2017 Dec 10;267:172-180. doi: 10.1016/j.jconrel.2017.08.014. Epub 2017 Aug 15.

PMID:
28821462
6.

Ferritin nanocages: A biological platform for drug delivery, imaging and theranostics in cancer.

Truffi M, Fiandra L, Sorrentino L, Monieri M, Corsi F, Mazzucchelli S.

Pharmacol Res. 2016 May;107:57-65. doi: 10.1016/j.phrs.2016.03.002. Epub 2016 Mar 9. Review.

7.

Nanostructured cubosomes as a platform for oral drug delivery.

Liu M, Chen M, Xu P, Yang Z.

Curr Pharm Biotechnol. 2015;16(4):313-21. Review.

PMID:
25601599
8.

Targeted tumor delivery and controlled release of neuronal drugs with ferritin nanoparticles to regulate pancreatic cancer progression.

Lei Y, Hamada Y, Li J, Cong L, Wang N, Li Y, Zheng W, Jiang X.

J Control Release. 2016 Jun 28;232:131-42. doi: 10.1016/j.jconrel.2016.03.023. Epub 2016 Apr 2.

PMID:
27046157
9.

Stimuli-responsive polymeric micelles for drug delivery and cancer therapy.

Zhou Q, Zhang L, Yang T, Wu H.

Int J Nanomedicine. 2018 May 18;13:2921-2942. doi: 10.2147/IJN.S158696. eCollection 2018. Review.

10.

Andrographolide-loaded polymerized phenylboronic acid nanoconstruct for stimuli-responsive chemotherapy.

Kim J, Lee J, Lee YM, Pramanick S, Im S, Kim WJ.

J Control Release. 2017 Aug 10;259:203-211. doi: 10.1016/j.jconrel.2016.10.029. Epub 2016 Oct 28.

PMID:
27984106
11.

Hyaluronic acid-conjugated apoferritin nanocages for lung cancer targeted drug delivery.

Luo Y, Wang X, Du D, Lin Y.

Biomater Sci. 2015 Oct 15;3(10):1386-94. doi: 10.1039/c5bm00067j. Epub 2015 Aug 24.

PMID:
26301700
12.

Ferritins as nanoplatforms for imaging and drug delivery.

Zhen Z, Tang W, Todd T, Xie J.

Expert Opin Drug Deliv. 2014 Dec;11(12):1913-22. doi: 10.1517/17425247.2014.941354. Epub 2014 Jul 29. Review.

13.

Protein nanocages for self-triggered nuclear delivery of DNA-targeted chemotherapeutics in Cancer Cells.

Bellini M, Mazzucchelli S, Galbiati E, Sommaruga S, Fiandra L, Truffi M, Rizzuto MA, Colombo M, Tortora P, Corsi F, Prosperi D.

J Control Release. 2014 Dec 28;196:184-96. doi: 10.1016/j.jconrel.2014.10.002. Epub 2014 Oct 13.

PMID:
25312541
14.

Cisplatin encapsulation within a ferritin nanocage: a high-resolution crystallographic study.

Pontillo N, Pane F, Messori L, Amoresano A, Merlino A.

Chem Commun (Camb). 2016 Mar 18;52(22):4136-9. doi: 10.1039/c5cc10365g.

PMID:
26888424
15.

Tailoring of physicochemical properties of nanocarriers for effective anti-cancer applications.

Chakraborty S, Dhakshinamurthy GS, Misra SK.

J Biomed Mater Res A. 2017 Oct;105(10):2906-2928. doi: 10.1002/jbm.a.36141. Epub 2017 Jul 14. Review.

PMID:
28643475
16.

Apoferritin as an ubiquitous nanocarrier with excellent shelf life.

Dostalova S, Vasickova K, Hynek D, Krizkova S, Richtera L, Vaculovicova M, Eckschlager T, Stiborova M, Heger Z, Adam V.

Int J Nanomedicine. 2017 Mar 24;12:2265-2278. doi: 10.2147/IJN.S130267. eCollection 2017.

17.

Nano-aggregates: emerging delivery tools for tumor therapy.

Sharma VK, Jain A, Soni V.

Crit Rev Ther Drug Carrier Syst. 2013;30(6):535-63. Review.

PMID:
24099399
18.

Site-Directed Conjugation of Antibodies to Apoferritin Nanocarrier for Targeted Drug Delivery to Prostate Cancer Cells.

Dostalova S, Cerna T, Hynek D, Koudelkova Z, Vaculovic T, Kopel P, Hrabeta J, Heger Z, Vaculovicova M, Eckschlager T, Stiborova M, Adam V.

ACS Appl Mater Interfaces. 2016 Jun 15;8(23):14430-41. doi: 10.1021/acsami.6b04286. Epub 2016 Jun 2.

PMID:
27219717
19.

Multifunctional upconversion mesoporous silica nanostructures for dual modal imaging and in vivo drug delivery.

Li C, Yang D, Ma P, Chen Y, Wu Y, Hou Z, Dai Y, Zhao J, Sui C, Lin J.

Small. 2013 Dec 20;9(24):4150-9. doi: 10.1002/smll.201301093. Epub 2013 Jul 11.

PMID:
23843254
20.

Graphene-based nanosheets for delivery of chemotherapeutics and biological drugs.

Shim G, Kim MG, Park JY, Oh YK.

Adv Drug Deliv Rev. 2016 Oct 1;105(Pt B):205-227. doi: 10.1016/j.addr.2016.04.004. Epub 2016 Apr 13. Review.

PMID:
27085467

Supplemental Content

Support Center